Page last updated: 2024-12-11

sri 224

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9561005
CHEMBL ID223505
MeSH IDM0453807

Synonyms (14)

Synonym
[(e)-1-(4-methoxyphenyl)ethylideneamino]thiourea
sri-224
AKOS000506378
CHEMBL223505 ,
p-methoxyphenyl(methyl)thiosemicarbazone
bdbm50302754
9P-047
[(e)-[1-(4-methoxyphenyl)ethylidene]amino]thiourea
150059-53-3
2-[(e)-1-(4-methoxyphenyl)ethylidene]-1-hydrazinecarbothioamide
sr-01000310617
SR-01000310617-1
(1e)-1-(4-methoxyphenyl)ethanone thiosemicarbazone
mfcd00808617
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)0.11000.03403.987110.0000AID444073
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID178190Effective dose for protection against seizures induced in the maximal electroshock anticonvulsant screen test 1 hr after oral dosing in rat1993Journal of medicinal chemistry, Aug-06, Volume: 36, Issue:16
Anticonvulsant activities of some arylsemicarbazones displaying potent oral activity in the maximal electroshock screen in rats accompanied by high protection indices.
AID190125Neurotoxicity was determined, 1 hr after oral dosing in rat.1993Journal of medicinal chemistry, Aug-06, Volume: 36, Issue:16
Anticonvulsant activities of some arylsemicarbazones displaying potent oral activity in the maximal electroshock screen in rats accompanied by high protection indices.
AID598528Inhibition of alpha-MSH-induced melanin production in mouse B16 cells at 10 uM after 3 days2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition.
AID283663Antimycobacterial activity against Mycobacterium bovis BCG NCTC 56922007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID598529Inhibition of alpha-MSH-induced melanin production in mouse B16 cells after 3 days2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition.
AID283671Antimycobacterial activity against Mycobacterium bovis BCG str. Pasteur 1173P2 overexpressing ethA gene2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID444073Inhibition of mushroom tyrosinase2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Discovery of 4-functionalized phenyl-O-beta-D-glycosides as a new class of mushroom tyrosinase inhibitors.
AID283664Antimycobacterial activity against Mycobacterium bovis BCG NCTC 5692 with ethR-knockout mutant2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID1659814Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in mycolic acids synthesis after 8 hrs in presence of [1, 2-14C]-acetate by TLC analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
Molecule Property Analyses of Active Compounds for
AID283670Antimycobacterial activity against Mycobacterium bovis BCG str. Pasteur 1173P2 overexpressing ethR gene2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID283662Antimycobacterial activity against Mycobacterium tuberculosis H37Rv2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID283669Antimycobacterial activity against Mycobacterium bovis BCG Pasteur with pMV261 vector2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]